Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Neonatal Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • cGMP CliniControl™ Products
      • Human Primary Cells
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
    • Engineered Human Cell Lines
      • hTERT-Modified hMSCs
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Press Releases

RoosterBio Radically Simplifies Online Ordering Experience

January 21, 2020

RoosterBio Expands Facility for Second Time in 2019

December 18, 2019

Australian Patent Office Grants Patent Covering RoosterBio’s Novel Compositions and Formulations for Ready-to-Print (RTP) Cells

September 30, 2019

RoosterBio Closes Final Tranche of Oversubscribed $21.5 Million Series B Raise and Appoints Daniella Kranjac to the Board

September 10, 2019

RoosterBio Launches the Only Umbilical Cord hMSC System in the World Designed for Cell Therapy Product Development

September 6, 2019

RoosterBio Cell Manufacturing Experts and Biomanufacturing Leaders to Discuss hMSC BioProcess Solutions at Biotech Week Boston

September 4, 2019

RoosterBio Raises $15 Million in Initial Series B Round Led by Dynamk Capital

August 6, 2019

RoosterBio Named a 2019 Best Place to Work

August 1, 2019

RoosterBio’s Ready to Print MSCs Used in Partnership with nScript, U.S. Military, the Uniformed Services University 4D Bio3 Program to Test Bioprinter

July 10, 2019

RoosterBio Receives Grant from Maryland Stem Cell Research Fund to Commercialize MSC-EV Technology

June 13, 2019
Previous 1 2 3 4 5 6 7 8 Next

Sidebar Navigation

  • News
  • Events
  • Press Releases
  • Media Kit

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2026 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email